--- title: "Gestational Diabetes Mellitus: is it possible to detect it early in pregnancy by continuously monitoring glucose and personal health metrics?" description: Early Detection and management of GDM allows early-stage interventions, providing opportunities to durably impact and decrease NCDs. image: https://blog.pqegroup.com/hubfs/Gestational%20Diabetes%20Mellitus_Site%20Banner.jpg --- [![Logo PQE Group - azzurro - 2024](https://blog.pqegroup.com/hs-fs/hubfs/Logo%20PQE%20Group%20-%20azzurro%20-%202024.png?width=2000&height=721&name=Logo%20PQE%20Group%20-%20azzurro%20-%202024.png "Logo PQE Group - azzurro - 2024")](https://www2.pqegroup.com) - [Home](https://www2.pqegroup.com/) - [Industry](https://www2.pqegroup.com/industry/) - [Pharma & API](https://www2.pqegroup.com/pharma-api/) - [Medical Device](https://www2.pqegroup.com/medical-device/) - [Biotech](https://www2.pqegroup.com/biotech/) - [Startup](https://www2.pqegroup.com/startup/) - [Veterinary](https://www2.pqegroup.com/veterinary/) - [Services](https://www2.pqegroup.com/services/) - [Data Integrity](https://www2.pqegroup.com/data-integrity/) - [Digital Governance](https://www2.pqegroup.com/digital-governance/) - [Engineering](https://www2.pqegroup.com/engineering/) - [Commissioning, Qualification and Validation (CQV)](https://www2.pqegroup.com/commissioning-qualification-validation/) - [Quality Compliance](https://www2.pqegroup.com/quality-compliance/) - [Laboratory Excellence](https://www2.pqegroup.com/laboratory-excellence/) - [Regulatory Affairs](https://www2.pqegroup.com/regulatory-affairs/) - [Audits](https://www2.pqegroup.com/audits/) - [Training](https://www2.pqegroup.com/training/) - [Clinical Research](https://www2.pqegroup.com/clinical-research-services/) - [Pharmacovigilance](https://www2.pqegroup.com/pharmacovigilance/) - About - [About Us](https://www2.pqegroup.com/about/) - [ESG](https://www2.pqegroup.com/about/csr/) - [Women in STEM](https://www2.pqegroup.com/about/women-in-stem/) - Resources - [News & Press](https://www2.pqegroup.com/news/) - [Webinars](https://www2.pqegroup.com/webinars/) - [Blog](https://blog.pqegroup.com/) - [Careers](https://www2.pqegroup.com/careers/) - [Contact Us](https://www2.pqegroup.com/contact-us/) ![](https://blog.pqegroup.com/hubfs/blank-user.png) Giora Bar-Sakai COO at Wear-2B # **Gestational Diabetes Mellitus: is it possible to detect it early in pregnancy by continuously monitoring glucose and personal health metrics?** [FemTech](https://blog.pqegroup.com/tag/femtech) ## Gestational diabetes mellitus (GDM) Gestational diabetes mellitus (GDM) reflects a marked intolerance to glucose consumption during pregnancy. There is no universal definition, although a biological consensus is based upon the results of a glucose tolerance test performed at mid-gestation. This has revealed a sustained increase in the prevalence of GDM worldwide, particularly marked in middle income countries both within and outside Europe affecting 8 to 30% of all pregnant women depending on the country.   The epidemic prevalence of gestational diabetes is both alarming and consequential, as adverse effects can be NCDs on both the mother and the offspring. There is a lack of overall knowledge with only a few identified risk factors and a too late diagnosis for an optimal management of GDM and its consequences. A previous diagnosis of gestational diabetes (GDM) carries a lifetime risk of progression to type 2 diabetes of up to 60%. Identification of those women at higher risk of progression to diabetes allows the timely introduction of measures to delay or prevent diabetes onset and is an easily identifiable high-risk group.  But it does not stop at the mother: very little is known about the impact that gestational diabetes has on the offspring, and the epidemiology is not minimal: 1 in 6 live births are impacted by gestational diabetes. The literature points to an increased risk of obesity in childhood and cardiovascular disease traits in adulthood - GDM therefore durably impacting the health of the future citizens paving their way into metabolic syndromes.  Early Detection and management of GDM allows early-stage interventions, providing opportunities for clinicians, citizens, and policy makers, to durably impact and decrease NCDs.   ### *Wizmi* : non-invasive, continues glucose monitoring & personal health metrics  Wear2b, founded in 2015 by experienced team with proven track record in bringing revolutionary products to market and building NASDAQ traded company, has developed a patented solution for **non-invasive, continuous, real-time monitoring** of personal health parameters in the blood.  *Wizmi*, our first product, is a novel wrist band wearable device that provides non-invasive continuous **measurements of glucose**, **heart rate** and **blood lipids** for prediction, analysis and monitoring of metabolic disorders, to maintain **normal blood sugar levels**, make better dietary nutrition choices and **improve overall personal health**.   *Wizmi* is based on our patented & proprietary technology using our novel **non-invasive opto-bio sensor**. We use diffusive spectroscopy, biology, electro-optics, cloud computing and algorithms to build a unique multi trajectories analysis utilizing elements' reduction technology to achieve superior SNR (Signal to Noise Ratio) for better and improved accuracy.    **Author's note: ** *Wear-2B is committed to improve the lives of people with glucose related issues and specifically Women’s Health: 135 million live births occur every year, 1 of 6 to women with hyperglycemia, 84% of with GDM.* *By continuously collecting metabolic data from the 1st Trimester, Wizmi users and healthcare providers can predict  GDM during early stages of pregnancy and enable monitoring and normalization of blood glucose values for normal maternal, fetal and neonatal outcomes. *   ![Giora Bar Sakai-1](https://blog.pqegroup.com/hs-fs/hubfs/Giora%20Bar%20Sakai-1.png?width=150&height=150&name=Giora%20Bar%20Sakai-1.png) **[Giora Bar-Sakai](https://www.linkedin.com/in/giora-bar-sakai-330b45/)** COO Wear-2B   ---   ##### Join the FemTech revolution [         Discover more         ](https://www2.pqegroup.com/femtech/) ![Gestational Diabetes Mellitus_Site Banner](https://blog.pqegroup.com/hs-fs/hubfs/Gestational%20Diabetes%20Mellitus_Site%20Banner.jpg?width=2000&name=Gestational%20Diabetes%20Mellitus_Site%20Banner.jpg) ## Want to learn more about the rise of FemTech? Visit our [FemTech](https://www2.pqegroup.com/femtech/) dedicated page or get in touch with us to learn how PQE Group can help your business. [Contact us](https://www2.pqegroup.com/contact-us/) #### More on this topic [FemTech ![Breast Cancer Awareness Month: FemTech and Innovation in the Global Fight Against Breast Cancer](https://blog.pqegroup.com/hubfs/BANNER_Breast%20Cancer%20Awareness%20Month.jpg)](https://blog.pqegroup.com/femtech/breast-cancer-awareness-month-femtech-and-innovation-in-the-global-fight-against-breast-cancer) 04 Sep 2025 ## [Breast Cancer Awareness Month: FemTech and Innovation in the Global Fight Against Breast Cancer Discover how FemTech and AI are reshaping the global fight against breast cancer. PQE Group drives innovation and awareness.](https://blog.pqegroup.com/femtech/breast-cancer-awareness-month-femtech-and-innovation-in-the-global-fight-against-breast-cancer) [FemTech ![Meet the Online Communities Writing the Future of FemTech and Women's Health](https://blog.pqegroup.com/hubfs/BANNER_Online%20communities%20%20shaping%20the%20future%20of%20FemTech.jpg)](https://blog.pqegroup.com/femtech/meet-the-online-communities-writing-the-future-of-femtech-and-womens-health) 28 Aug 2025 ## [Meet the Online Communities Writing the Future of FemTech and Women's Health Discover how online communities are reshaping FemTech, empowering women, and redefining the future of women’s health](https://blog.pqegroup.com/femtech/meet-the-online-communities-writing-the-future-of-femtech-and-womens-health) [FemTech ![The Critical Role of Data in Advancing FemTech](https://blog.pqegroup.com/hubfs/Data%20In%20FemTech_Blog.jpg)](https://blog.pqegroup.com/femtech/the-critical-role-of-data-in-advancing-femtech) 19 Jun 2025 ## [The Critical Role of Data in Advancing FemTech Discover how clinical data, AI, and technology are transforming FemTech to close the gender health gap and enable personalized care for women](https://blog.pqegroup.com/femtech/the-critical-role-of-data-in-advancing-femtech) ![new PQE logo white tagline](https://blog.pqegroup.com/hubfs/new%20PQE%20logo%20white%20tagline.png) ISO 9001 Certified compliance services provider since 1998.   ![Logo ISO 9001](https://blog.pqegroup.com/hs-fs/hubfs/Logo%20ISO%209001.png?width=125&name=Logo%20ISO%209001.png)   - Discover PQE - [Work with PQE](https://www2.pqegroup.com/careers/) - [Locations](https://www2.pqegroup.com/contact-us/#locations) - [About](https://www2.pqegroup.com/about/) - [Blog](https://blog.pqegroup.com/) - Useful Links - [Privacy Notice](https://www2.pqegroup.com/privacy-notice/) - [Cookie Policy](https://www2.pqegroup.com/cookie-policy/) - [Model of Organization](https://www2.pqegroup.com/model-of-organization/) - [Ethical Code](https://www2.pqegroup.com/ethical-code/) English - [English](https://blog.pqegroup.com/femtech/gestational-diabetes-mellitus-early-detection-in-pregnancy-through-monitoring-of-glucose-and-personal-health-metrics) - [Deutsch](https://blog.pqegroup.com/de/femtech/schwangerschaftsdiabetes-mellitus-fruherkennung-in-der-schwangerschaft-durch-uberwachung-von-glukose-und-personlichen-gesundheitsmetriken) - [Español - España](https://blog.pqegroup.com/es-es/femtech/diabetes-miellitus-gestacional-como-detectarla-precozmente-en-el-embarazo) - [Español - México](https://blog.pqegroup.com/es-mx/femtech/diabetes-miellitus-gestacional-como-detectarla-precozmente-en-el-embarazo) - [Français](https://blog.pqegroup.com/fr/femtech/diabete-gestationnel-sucre-detection-precoce-pendant-la-grossesse-grace-surveillance-de-la-glycemie-et-parametres-de-sante-personnels) - [Polski](https://blog.pqegroup.com/pl/femtech/cukrzyca-ciążowa-wykrywanie-we-wczesnej-ciąży-poprzez-monitorowanie-poziomu-glukozy-i-wskaźników-zdrowia-osobistego) - [Português - Brasil](https://blog.pqegroup.com/pt-br/femtech/diabetes-mellitus-gestacional-e-possivel-detecta-lo-no-inicio-da-gravidez-por-meio-do-monitoramento-continuo-da-glicose-e-das-metricas-pessoais-de-saude) - [עברית](https://blog.pqegroup.com/he/femtech/gestational-diabetes-mellitus-early-detection-in-pregnancy-through-monitoring-of-glucose-and-personal-health-metrics) - [日本語](https://blog.pqegroup.com/ja/femtech/gestational-diabetes-mellitus-early-detection-in-pregnancy-through-monitoring-of-glucose-and-personal-health-metrics) - [简体中文](https://blog.pqegroup.com/zh-cn/femtech/gestational-diabetes-mellitus-early-detection-in-pregnancy-through-monitoring-of-glucose-and-personal-health-metrics) CHANGE LANGUAGE Copyright **2024** | Proudly powered by **PQE Group Creative Team** [LinkedIn](https://www.linkedin.com/company/pqe-group) [![twitter](https://blog.pqegroup.com/hubfs/twitter-w.png) Twitter](https://twitter.com/PQEGroup) [Facebook](https://www.facebook.com/PQEGroup/) [Instagram](https://www.instagram.com/lifeatpqe) [YouTube](https://www.youtube.com/c/PQEGroup) [Xing](https://www.xing.com/pages/pqegroup)